Source: Eur Respir J 2010; 36: 1220-1221
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Birrell M.A., Van Oosterhout A.J.M., Belvisi M.G.. Do the current house dust mite-driven models really mimic allergic asthma?. Eur Respir J 2010; 36: 1220-1221

Member's Comments

No comment yet.

Related content which might interest you: Calcaratarin D attenuates house dust mite-induced allergic asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Monitoring spirometry-like parameters in mice with house dust mite-induced experimental asthma Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease Year: 2021 Inflammatory and remodeling events in a murine model of asthma according to chronic exposure to house dust mite Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007 Sublingual immunotherapy is an established therapy for house dust mite sensitive allergic rhinitis and/or asthma Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities Year: 2007 OPURIT: Omalizumab-protected ultra rush specific immunotherapy in severe asthmatic patients with house dust mite allergy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Circulating platelets activity in patients sensitised to house dust mite suffering from persistent allergic rhinitis with or without asthma symptoms Source: Eur Respir J 2005; 26: Suppl. 49, 590s Year: 2005 House dust mite induces direct airway inflammation in vivo: implications for future disease therapy? Source: Eur Respir J 2010; 35: 1377-1387 Year: 2010 Poly:IC causes exacerbation in a murine allergic inflammation model driven by house dust mite in Freund‘s complete adjuvant Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 A house dust mite-induced asthma model in transcutaneously sensitized mice Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 House dust mite sublingual immunotherapy reduces type 2 biomarkers in allergic asthma Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 The effect of BCG treatment on the remodelling in the house dust mite induced allergic asthma in mice Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005 Implication of NOD-1 receptor in an experimental house dust mite-induced asthma model Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Effect of house dust mite sublingual immunotherapy on airway inflammation and remodeling in allergic asthma with rhinitis Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Long-term exposure to close-proximity air pollution and asthma and allergies in urban children Source: Eur Respir J 2010; 36: 33-40 Year: 2010 Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Hypoallergenic high dose scit as add-on therapy in children with allergic asthma caused by house dust mites Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Efficacy of specific allergy vaccination in house dust mite asthma Source: Eur Respir J 2005; 26: Suppl. 49, 465s Year: 2005 Grass pollen allergen induces asthma symptoms in a murine model of acute allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 587s Year: 2005 High-altitude treatment in atopic and nonatopic patients with severe asthma Source: Eur Respir J 2012; 40: 1374-1380 Year: 2012 Oral presentation: Early sources of IL-13 in house dust mite-induced neonatal allergic airways disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013